Olshan Client Pharmacyclics Enjoys Significant Growth in 2013

Firm News

The Wall Street Journal reported that small-company stocks have produced large returns in 2013 so far, particularly in recent weeks, according to the Russell 2000 index. One of the companies enjoying this surge of investor interest is Olshan client Pharmacyclics Inc., which has gained 81% this year. Olshan represents Pharmacyclics in connection with its corporate and securities matters.

Media Contact

Marketing Contact
Mizi Mehaj
Marketing & Administrative Manager

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.